The firm upped its rating on the social media website based on a recent pullback in shares and a valuation call.
Must Read: Warren Buffett's 10 Favorite Growth Stocks
Get your notepad out. Apple might not make it to $1 trillion.
With a 100-plus-year history, generous dividend, and diversified portfolio, could this Big Pharma player be resistant to Trump's drug price twitterstorm?
Not everyone can win, after all.
It increasingly seems as if Twitter is more focused on better appealing to its core users than gaining new converts. That will only get it so far.